reviewThe LancetFeb 25, 2019Closed access

Autosomal dominant polycystic kidney disease

ÉCÉmilie Cornec-Le Gall AAAhsan Alam RDRonald D. Perrone

Centre Hospitalier Régional Universitaire de Brest · Université de Bretagne Occidentale · +4 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

594

total citations

FWCI: 42.28
Percentile: 100%
References: 144

Citations per year

Authors

3

ÉC
Émilie Cornec-Le Gall
Centre Hospitalier Régional Universitaire de Brest, Université de Bretagne Occidentale, Génétique, Génomique Fonctionnelle et Biotechnologies, Inserm
AA
Ahsan Alam
McGill University Health Centre
RD
Ronald D. PerroneCorresponding
Tufts Medical Center

Topics & keywords

Topics

Keywords

Medicine
Autosomal dominant polycystic kidney disease
Disease
Kidney disease
Tolvaptan
Intensive care medicine
Polycystic kidney disease
Clinical trial

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.